Management and prognosis of endometrioid borderline tumors of the ovary.
Uzan C, Berretta R, Rolla M, Gouy S, Fauvet R, Darai E, Duvillard P, Morice P.
Surg Oncol. 2012 Sep;21(3):178-84. doi: 10.1016/j.suronc.2012.02.002. Epub 2012 Mar 13.
PMID:22418038
Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE.
Morice P, Scambia G, Abu-Rustum NR, Acien M, Arena A, Brucker S, Cheong Y, Collinet P, Fanfani F, Filippi F, Eriksson AGZ, Gouy S, Harter P, Matias-Guiu X, Pados G, Pakiz M, Querleu D, Rodolakis A, Rousset-Jablonski C, Stepanyan A, Testa AC, Macklon KT, Tsolakidis D, De Vos M, Planchamp F, Grynberg M.
Lancet Oncol. 2024 Nov;25(11):e602-e610. doi: 10.1016/S1470-2045(24)00262-6. Epub 2024 Aug 28.
PMID:39216500
Adenomatoid tumor of the uterus: analysis of misdiagnosed cases and a literature review.
Li YY, Kan GJ, Wang Q, Guo S, Wu CX, Zhu J.
J Int Med Res. 2024 Oct;52(10):3000605241282389. doi: 10.1177/03000605241282389.
PMID:39394879
Use of HC2 to triage women with borderline and mild dyskaryosis in the UK.
Arbyn M, Roelens J, Martin-Hirsch P, Leeson S, Wentzensen N.